The availability of inhaled insulin may increase the number of patients with uncontrolled type 2 diabetes who are willing to start or intensify insulin therapy.
Read More »Insulin Aspart Safe During Pregnancy
Use of the rapid-acting insulin analogue insulin aspart, as a component of basal-bolus therapy with NPH insulin, indicates that it is as safe and effective as regular human insulin in pregnant women with type 1 diabetes.
Read More »Cut Heart Risk by Eating Less Salt: New Study
Studies show a lower-salt diet lowers risk of heart disease and stroke. “Americans consume much more sodium than is necessary and it comes mostly from processed foods and the foods we eat in restaurants.”
Read More »High Serum Selenium Levels Linked to Increased Diabetes Risk
Contrary to expectation, high serum selenium levels are positively associated with the prevalence of diabetes, according to findings published in the April issue of Diabetes Care.
Read More »Diabetes Among Indigenous People Not From Their Genetic Heritage?
The high rate of diabetes among indigenous people is not due to their genetic heritage, according to a recently published study.
Read More »Patients with Psoriasis Prone to Diabetes and Serious Cardiovascular Condition
New research suggests an association between psoriasis and two potentially serious medical conditions – diabetes and atherosclerosis.
Read More »Traditional Insulin Compares Well Against Analogs
Newer long-acting insulin analogs are only marginally better at preventing nighttime hypoglycemia than traditional NPH insulin, found investigators here in a systematic review.
Read More »CMS Proposes Unique Codes For Continuous Glucose Monitoring
CMS is proposing to establish unique codes for continuous glucose monitors, a decision that could help manufacturers secure reimbursement from both Medicare and private payors.
Read More »Type 2 Diabetes Often Asymptomatic in Children
The overall prevalence of type 2 diabetes has increased 5-fold in the United States since the 1960s, and children and adolescents are among those affected. However, children often exhibit no symptoms.
Read More »Adiponectin: An Ally In Reducing Cardiometabolic Risk Factors
Every time I read a news-feed it has something about how we are losing the battle against diabetes, pre-diabetes, and metabolic syndrome. Phil Wood DVM, MS, PhD focuses on Adiponectin: An Ally In Reducing Cardiometabolic Risk Factors and shows that there is a growing interest in understanding the role of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.